Company Profile LogoMedibio

Medibio is the World’s First Developer of an objective test for the diagnosis of depression & other Mental Health disorders.

Edit IconSuggest an Edit
Health Diagnostics
Health Care
Mental Health
Biotechnology

    Unlock insights on Medibio and 2M+ companies now!

    About Medibio

    Medibio (ASX: MEB) (OTCQB: MDBIF) is a digital health company that has developed an objective test to assist in the diagnosis of depression, chronic stress and other mental health disorders. Based on research conducted over 15 years at the University of Western Australia, this test utilizes patented (and patent pending) circadian heart rate variability and cloud based proprietary algorithms delivering a quantifiable measure to assist in clinical diagnosis. Medibio’s depression diagnostic is bein

    Company Highlights
    Year Founded

    1987

    icon-altEmployees

    13

    Location (HQ)

    AUS

    Since Last Funding

    3 years 7 months

    Monthly Website Visitors

    4.2K

    icon-altTotal Investment Amt

    $35M

    Last Funding Round

    Post Ipo Equity

    icon-altYoY Headcount Growth

    -13.25%

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Health Care

    Health Diagnostics

    Biotechnology

    Mental Health

    Mental Health Care